Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism

Winnie Deuther-Conrad, Claudia Loske, Reinhard Schinzel, Ralf Dringen, Peter Riederer, Gerald Münch

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Abstract

The reaction of proteins with reducing sugars leads to the formation of 'advanced glycation endproducts' (AGEs). They accumulate in Alzheimer's disease brain in the vicinity of β-amyloid plaques. AGEs are cytotoxic by a mechanism involving reactive oxygen species, which implies that they could compromise glutathione redox status. In this study, we show that AGEs (BSA-AGE and β-amyloid-AGE) persistently increase the ratio of oxidized to reduced glutathione in a dose- and time-dependent manner in SH-SY5Y neuroblastoma cells. The level of oxidized glutathione accounted to 10-14% and persisted for up to 24 h in the presence of added AGEs. In contrast, the unmodified β-amyloid peptides Aβ (1-40) and Aβ (25-35) had no significant effect on glutathione redox status. The AGE-induced increase in oxidized glutathione could be prevented by the radical scavengers N-acetylcysteine, α-lipoic acid and 17β-estradiol or by application of catalase, indicating that superoxide and hydrogen peroxide production precedes the AGE-mediated depletion of reduced glutathione.

Original languageEnglish
Pages (from-to)29-32
Number of pages4
JournalNeuroscience Letters
Volume312
Issue number1
DOIs
Publication statusPublished - 12 Oct 2001
Externally publishedYes

Keywords

  • Advanced glycation endproducts
  • Alzheimer's disease
  • Antioxidants
  • Glutathione

Fingerprint

Dive into the research topics of 'Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism'. Together they form a unique fingerprint.

Cite this